U.S. Markets open in 42 hrs, 8 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
| Day Low | 8.13 03:30 PM EDT | |
|---|---|---|
| Day High | 8.50 09:30 AM EDT |
|
| Range | 0.37 |
| Volume | 803,565 | |
|---|---|---|
| 30-Day Avg Vol | 812,000 |
|
| Difference | -1.04% |
| Market Cap | 731.86 M | |
|---|---|---|
| Mkt Cap Chg | -24.12 M |
| Shares Out | 89.36 M | |
|---|---|---|
| % Shrs Traded | 0.90% | |
| 1yr EPS Est | -0.734 |
| 52-Wk Low | 3.82 10/10/08 | |
|---|---|---|
| 52-Wk High | 10.19 8/11/08 |
|
| Range | 6.37 |
| Prev Close | 8.46 7/1/09 | |
|---|---|---|
| Today's Open | 8.50 | |
| Change | 0.47% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 3.68 M |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -51.73 M | |
| Earnings (MRQ) | -15.15 M | |
| Next Earn Est | -0.174 | |
| Next Earnings | 08/05/2009 |
|
| EPS (TTM) | -0.69 | |
| 1yr EPS Growth | -6.38% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -11.00 | |
| PEG Ratio | — | |
| Return on Equity | -78.61 | |
| Beta | 0.61 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more infoDrug developer Allos Therapeutics is looking for the next big breakthrough in the fight against cancer. Its lead candidate PDX (pralatrexate) is undergoing clinical trials for a relatively rare blood cancer ... View Full Description

| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.174 8/5/09 | — — |
—
—
|
| Last Quarter | -0.174 3/31/09 | -0.19 3/31/09 |
-0.016
Missed
|
| 2 Quarters Ago | -0.164 12/31/08 | -0.18 12/31/08 |
-0.016
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | -1.95 M | -392,736.00 |
| Operating Income | -15.32 M | -53.64 M |
| Net Income | -15.15 M | -51.73 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.